Intracellular delivery of large molecules and small particles by cell-penetrating proteins and peptides
Introduction
Many biologically active compounds, including various large molecules, need to be delivered intracellularly to exert their therapeutic action inside cytoplasm or onto nucleus or other specific organelles, such as mitochondria. However, the lipophilic nature of the biological membranes restricts the direct intracellular delivery of such compounds. Moreover, large molecules such as DNA, which are internalized via endocytosis [1] and transferred within endosomes, end in lysosomes resulting in the degradation of these molecules by lysosomal enzymes. So although many compounds show a promising potential in vitro, they cannot be used in vivo due to bioavailability problems. The methods like microinjection or electroporation used for the delivery of membrane-impermeable molecules are invasive in nature and could damage cellular membrane [2], [3]. The non-invasive methods involve the use of pH-sensitive carriers including pH-sensitive liposomes [4], which under the low pH inside endosomes destabilize endosomal membrane liberating the entrapped drug into the cytoplasm.
A novel approach to deliver such molecules involves tethering them to peptides that can translocate through the cellular membranes, thereby enhancing their delivery inside the cell. During the last decade, several proteins and peptides have been found to traverse through the cellular membranes in a process called “Protein Transduction”, delivering their cargo molecules into the cytoplasm and/or nucleus. These proteins and peptides have been used for intracellular delivery of various cargoes with molecular weights several times greater than their own [5]. This process of protein transduction was discovered first by Green and Frankel independently, who found that 86-mer trans-activating transcriptional activator (TAT) from HIV-1 was efficiently taken up by various cells, when added to the surrounding media [6], [7]. Subsequently, this property of translocation was found in Antennapedia (Antp), a transcription factor of Drosophila [8], and VP22, a herpes virus protein [9]. More precisely, their ability to translocate across the plasma membranes is confined to short sequences of less than 20 amino acids, which are highly rich in basic residues. Such sequences are called “Protein Transduction Domains (PTDs)” or “Cell-Penetrating Peptides (CPPs)”. Cellular delivery using CPPs has several advantages over conventional techniques because it is efficient for a range of cell types, can be applied to cells en masse, and has a potential therapeutic application [10].
The details on the nature of CPPs and their proposed mechanisms of translocation are discussed in other articles of this issue. However, we still will provide here a brief description of some of CPPs involved in delivery of therapeutic agents, and then focus mainly on applications of CPPs for various biomedical purposes.
Section snippets
Cell-penetrating peptides (CPPs)
CPPs are divided into two classes: the first class consists of amphipathic helical peptides, such as transportan and model amphipathic peptide (MAP), where lysine (Lys) is the main contributor to the positive charge, while the second class includes arginine (Arg)-rich peptides, such as TAT (48–60) and Antp or penetratin [11].
Mechanisms of translocation
The internalization of TAT, Antp, and transportan was thought to follow non-saturable, dose-dependent kinetics. Initially, the uptake of these peptides was believed to occur efficiently both at 37 °C and at 4 °C, excluding the possibility of endocytosis [24], [29], [32].
The translocation of Antp did not involve receptor since both the reverse helix and the helix with d-enantiomers for the Antp peptide 43–58 were translocated across biological membranes [38]. The formation of inverted micelles
Intracellular delivery of large molecules and small particles
Since traversal through cellular membranes represents a major barrier for efficient delivery of macromolecules into cells, cell-penetrating peptides may serve to ferry various macromolecules into mammalian cells in vitro and in vivo. The use of peptides and protein domains with amphipathic sequences for drug and gene delivery across cellular membranes is getting increasing attention. Covalent hitching of proteins, drugs, DNA, or other macromolecules onto PTDs may circumvent conventional
Conclusions
In nutshell, protein transduction technology has shown enormous potential to deliver a wide range of large molecules and small particles both in vitro and in vivo. Various CPPs can be successfully used for the delivery of high-molecular-weight drugs and nanoparticular drug carriers into many cells as well as for vaccine development and imaging purposes. The application of the transduction technology is increasing in different areas of biomedicine because of unique opportunity of delivering
References (123)
- et al.
Receptor-mediated targeting of gene delivery vectors: insights from molecular mechanisms for improved vehicle design
Biotechnol. Bioeng.
(2000) - et al.
Transfer of monoclonal antibodies into mammalian cells by electroporation
J. Biol. Chem.
(1989) - et al.
Antiviral sTATe against influenza virus neutralized by microinjection of antibodies to interferon-induced Mx proteins
EMBO J.
(1988) - et al.
pH-sensitive liposomes mediate cytoplasmic delivery of encapsulated macromolecules
FEBS Lett.
(1985) - et al.
In vivo protein transduction: intracellular delivery of biologically active proteins, compounds and DNA
Trends Pharmacol. Sci.
(2000) - et al.
Autonomous functional domains of chemically synthesized human immunodeficiency virus TAT trans-activator protein
Cell
(1988) - et al.
Cellular uptake of the TAT protein from human immunodeficiency virus
Cell
(1988) - et al.
Antennapedia homeobox peptide regulates neural morphogenesis
Proc. Natl. Acad. Sci. U. S. A.
(1991) - et al.
Intercellular trafficking and protein delivery by a herpesvirus structural protein
Cell
(1997) - et al.
Cell-penetrating peptides
Trends Pharmacol. Sci.
(2000)
Cargo delivery kinetics of cell-penetrating peptides
Biochim. Biophys. Acta
TAT protein from human immunodeficiency virus forms a metal-linked dimer
Science
Dimerization of the TAT protein from human immunodeficiency virus: a cysteine-rich peptide mimics the normal metal-linked dimer interface
Proc. Natl. Acad. Sci. U. S. A.
Structural and functional characterization of human immunodeficiency virus TAT protein
J. Virol.
Effects of a highly basic region of human immunodeficiency virus TAT protein on nucleolar localization
J. Virol.
Fragments of the HIV-1 TAT protein specifically bind TAR RNA
Science
Activity of synthetic peptides from the TAT protein of human immunodeficiency virus type 1
Proc. Natl. Acad. Sci. U. S. A.
Endocytosis and targeting of exogenous HIV-1 TAT protein
EMBO J.
Identification of an Arg-Gly-Asp (RGD) cell adhesion site in human immunodeficiency virus type 1 transactivation protein, TAT
J. Cell Biol.
Identification of a novel cell attachment domain in the HIV-1 TAT protein and its 90-kDa cell surface binding protein
J. Biol. Chem.
A novel integrin specificity exemplified by binding of the alpha v beta 5 integrin to the basic domain of the HIV TAT protein and vitronectin
J. Cell Biol.
Activating region of HIV-1 TAT protein: vacuum UV circular dichroism and energy minimization
Biochemistry
Structural and functional characterization of human immunodeficiency virus TAT protein
J. Virol.
A truncated HIV-1 TAT protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus
J. Biol. Chem.
MuTATional analysis of a human immunodeficiency virus type 1 TAT protein transduction domain which is required for delivery of an exogenous protein into mammalian cells
J. Gen. Virol.
Protein transduction: unrestricted delivery into all cells?
Trends Cell Biol.
Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery
J. Biol. Chem.
Homeodomain proteins
Annu. Rev. Biochem.
The third helix of the Antennapedia homeodomain translocates through biological membranes
J. Biol. Chem.
Herpes simplex virus type 1 tegument protein VP22 induces the stabilization and hyperacetylation of microtubules
J. Virol.
Mapping of herpes simplex virus-1 VP22 functional domains for inter- and subcellular protein targeting
Gene Ther.
Cell penetration by transportan
FASEB J.
Cellular uptake of an alpha-helical amphipathic model peptide with the potential to deliver polar compounds into the cell interior non-endocytically
Biochim. Biophys. Acta
Inhibition of nuclear translocation of transcription factor NF-kappa B by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence
J. Biol. Chem.
Novel cell permeable motif derived from the PreS2-domain of hepatitis-B virus surface antigens
Gene Ther.
Characterization of a class of cationic peptides able to faciliTATe efficient protein transduction in vitro and in vivo
Molec. Ther.
Liposome transduction into cells enhanced by haptotactic peptides (Haptides) homologous to fibrinogen C-termini
J. Control. Release
Cell internalization of the third helix of the Antennapedia homeodomain is receptor-independent
J. Biol. Chem.
Internalization of HIV-1 TAT requires cell surface heparan sulfate proteoglycans
J. Biol. Chem.
Nuclear targeting of macromolecular polyanions by an HIV-TAT derived peptide. Role for cell-surface proteoglycans
J. Biol. Chem.
Antennapedia and HIV transactivator of transcription (TAT) “protein transduction domains” promote endocytosis of high molecular weight cargo upon binding to cell surface glycosaminoglycans
J. Biol. Chem.
Evidence for a plasma membrane-mediated permeability barrier to TAT basic domain in well-differentiated epithelial cells: lack of correlation with heparan sulfate
Biochemistry
Efficiency of protein transduction is cell type-dependent and is enhanced by dextran sulfate
J. Biol. Chem.
Full-length proteins attached to the HIV TAT protein transduction domain are neither transduced between cells, nor exhibit enhanced immunogenicity
Gene Ther.
TAT peptide internalization: seeking the mechanism of entry
Curr. Prot. Pept. Sci.
Cell surface adherence and endocytosis of protein transduction domains
Molec. Ther.
Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake
J. Biol. Chem.
Positively charged DNA-binding proteins cause apparent cell membrane translocation
Biochem. Biophys. Res. Commun.
Endosome disruption enhances the functional nuclear delivery of TAT-fusion proteins
Biochem. Biophys. Res. Commun.
QuantiTATive comparison of membrane transduction and endocytosis of oligopeptides
Biochem. Biophys. Res. Commun.
Cited by (585)
Cell-penetrating peptides for transmucosal delivery of proteins
2024, Journal of Controlled ReleaseFocused ion beam-scanning electron microscopy provides novel insights of drug delivery phenomena
2024, Journal of Controlled ReleaseCurrent research status of anti-cancer peptides: Mechanism of action, production, and clinical applications
2023, Biomedicine and PharmacotherapyDiscovery of endosomalytic cell-penetrating peptides based on bacterial membrane-targeting sequences
2023, Bioorganic ChemistryChemistry of conjugation in drug delivery: The prospects of biodegradable bonds in polymer–drug conjugates
2023, Polymer-Drug Conjugates: Linker Chemistry, Protocols and Applications